Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin C Donaldson

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal AnalysisZhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical TrialAndrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Respiratory Research|July 16, 2020
The sputum microbiome is distinct between COPD and health, independent of smoking historyKoirobi Haldar, Leena George, Zhang Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational StudyMairi A MacLeod, Kristopher D Knott, James P Allinson, et al.
BMJ Open Respiratory Research|August 23, 2023
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaborationXander Bertels, Ahmed Edris, Judith Garcia-Aymerich, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
Cell Host & Microbe|May 19, 2023
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary diseaseWeijie Liang, Yuqiong Yang, Shenhai Gong, et al.
The Lancet. Respiratory Medicine|December 17, 2022
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort StudyDexter J Wiseman, Ryan S Thwaites, Andrew I Ritchie, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Structural Predictors of Lung Function Decline in Young Smokers with Normal SpirometryAndrew I Ritchie, Gavin C Donaldson, Eric A Hoffman, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Respiratory and Critical Care Medicine|December 17, 2020
Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal AnalysisZhang Wang, Nicholas Locantore, Koirobi Haldar, et al.
American Journal of Respiratory and Critical Care Medicine|April 9, 2020
Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical TrialAndrew I Ritchie, Simon E Brill, Ben H Vlies, et al.
Respiratory Research|July 16, 2020
The sputum microbiome is distinct between COPD and health, independent of smoking historyKoirobi Haldar, Leena George, Zhang Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational StudyMairi A MacLeod, Kristopher D Knott, James P Allinson, et al.
BMJ Open Respiratory Research|August 23, 2023
Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaborationXander Bertels, Ahmed Edris, Judith Garcia-Aymerich, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
Cell Host & Microbe|May 19, 2023
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary diseaseWeijie Liang, Yuqiong Yang, Shenhai Gong, et al.
The Lancet. Respiratory Medicine|December 17, 2022
Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard carePallav L Shah, Christopher M Orton, Beatriz Grinsztejn, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2024
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort StudyDexter J Wiseman, Ryan S Thwaites, Andrew I Ritchie, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Structural Predictors of Lung Function Decline in Young Smokers with Normal SpirometryAndrew I Ritchie, Gavin C Donaldson, Eric A Hoffman, et al.
Pageof 10